K944427 is an FDA 510(k) clearance for the CARRASYN FDG. Classified as Dressing, Wound And Burn, Hydrogel W/drug And/or Biologic (product code MGQ).
Submitted by Carrington Laboratories, Inc. (Irving, US). The FDA issued a Cleared decision on November 29, 1994 after a review of 78 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Carrington Laboratories, Inc. devices